ARTICLE | Clinical News
Ferric citrate: Phase III started
April 25, 2011 7:00 AM UTC
Japan Tobacco began a Japanese Phase III trial of Zerenex. The start triggers a $5 million milestone payment to Keryx from Japan Tobacco. Keryx received worldwide rights to Zerenex, including Japan, b...